U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 20 results

IODIDE ION

MORE DETAILS

09G4I6V86Q

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

Trifluoroacetic anhydride

MORE DETAILS

5ENA87IZHT

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

Dimethylamine

MORE DETAILS

ARQ8157E0Q

Status:
Possibly Marketed Outside US
First approved in 2016
Class (Stereo):
CHEMICAL (ACHIRAL)

Morpholine

MORE DETAILS

  8B2ZCK305O

Status:
Possibly Marketed Outside US
First approved in 2011
Class (Stereo):
CHEMICAL (ACHIRAL)
Morpholine salicylate is a derivative of salicylic acid. It is a non-steroidal anti-inflammatory drug and was marketed under a tradename Retarcyl, Dolical and Deposal.

POTASSIUM OXIDE

MORE DETAILS

58D606078H

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

Iodine, atomic

MORE DETAILS

5D3DB66WM3

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

POTASSIUM FLUORIDE TETRAHYDRATE

MORE DETAILS

1V272UD7M7

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

ETHYLENEDIAMINE DIHYDRIODIDE

MORE DETAILS

721M52NQ5L

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

POTASSIUM BISULFIDE

MORE DETAILS

SX1L03AL9I

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

Potassium iodide

MORE DETAILS

1C4QK22F9J

Status:
US Approved Rx (2002)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
9

Showing 1 - 10 of 20 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966